<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="46319">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02503241</url>
  </required_header>
  <id_info>
    <org_study_id>PRICESEOBESE</org_study_id>
    <nct_id>NCT02503241</nct_id>
  </id_info>
  <brief_title>Open Lung Strategy in Critically Ill Morbid Obese Patients</brief_title>
  <official_title>Open Lung Strategy in Critically Ill Morbid Obese Patients Lung Imaging and Heart-lung Interaction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this interventional crossover study in morbidly obese intubated and mechanically
      ventilated patients is to describe the respiratory mechanics and the heart-lung interaction
      at titrated positive end-expiratory pressure levels following a recruitment maneuver with
      transthoracic echocardiography and electric impedance tomography imaging.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obese patients under mechanical ventilation are more likely to develop atelectasis as a
      consequence of the increased abdominal weight. Atelectasis is the primary responsible for
      respiratory insufficiency and impossibility to wean obese patients from respiratory support.

      In a previous study we demonstrated the efficacy of the application of titrated PEEP levels
      following a recruitment maneuver in obese patients, i.e. improvement in respiratory
      mechanics and gas exchanges without negative hemodynamic effects.

      The application of lung and heat imaging will allow us to quantitatively describe:

        -  Increase in aerated lung tissue (reduction of atelectasis)

        -  Reduction of over-inflation of the ventilated regions

        -  Recoupling of ventilation and perfusion

        -  Improvement in right heart function by reduction of right heart afterload
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lung elastance</measure>
    <time_frame>intraoperative</time_frame>
    <description>Difference in lung elastance measured in cmH2O/L</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung mechanics - Compliance</measure>
    <time_frame>intraoperative</time_frame>
    <description>Difference in respiratory system, lung and chest wall compliance measured in mL/cmH2O</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung mechanics - Airway resistances</measure>
    <time_frame>intraoperative</time_frame>
    <description>Difference in resistances of the airways measured as cmH2O/L/sec (Raw)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung imaging - Lung collapse and lung over-distention</measure>
    <time_frame>intraoperative</time_frame>
    <description>Percentage of lung tissue collapsed and/or over-distended at different PEEP levels. Both collapse and over distention are measured as decrease in regional compliance measured through electrical impedance tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung imaging - Electrical impedance tomography ventilation data</measure>
    <time_frame>intraoperative</time_frame>
    <description>Difference in aeration (end expiratory lung impedance) and in distribution of ventilation (regional compliance) measured as difference in global an regional electrical impedance distribution</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamics - Blood pressure</measure>
    <time_frame>intraoperative</time_frame>
    <description>Changes in invasive arterial blood pressures (BP, mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamics - Heart rate</measure>
    <time_frame>intraoperative</time_frame>
    <description>Changes in heart rate (HR, bpm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamics - Central venous pressure</measure>
    <time_frame>intraoperative</time_frame>
    <description>Changes in central venous pressure (CVP, mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-abdominal pressure</measure>
    <time_frame>intraoperative</time_frame>
    <description>Changes in bladder pressure measured in mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gas Exchange - Oxygenation</measure>
    <time_frame>Baseline (PEEP 10 cmH2O), at titrated PEEP level, at titrated PEEP level after a recruitment maneuver and 24 hours after the performance of the study protocol</time_frame>
    <description>Difference in oxygenation measured in mmHg of PaO2/FiO2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gas Exchange - Arterial carbon dioxide</measure>
    <time_frame>Baseline (PEEP 10 cmH2O), at titrated PEEP level, at titrated PEEP level after a recruitment maneuver and 24 hours after the performance of the study protocol</time_frame>
    <description>Difference in arterial carbon dioxide measured in mmHg (PaCO2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung volumes - respiratory dead space</measure>
    <time_frame>Baseline (PEEP 10 cmH2O), at titrated PEEP level and at titrated PEEP level after a recruitment maneuver</time_frame>
    <description>Difference in dead space fraction measured as the ratio of death volume over the total tidal volume (Vd/Vt)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung imaging - Electrical impedance tomography perfusion data</measure>
    <time_frame>Baseline (PEEP 10 cmH2O) and at titrated PEEP level after a recruitment maneuver</time_frame>
    <description>Differences in distribution in lung perfusion measured as regional percentage of the total cardiac output</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right heart function - TAPSE</measure>
    <time_frame>Baseline (PEEP 10 cmH2O), at titrated PEEP level and at titrated PEEP level after a recruitment maneuver</time_frame>
    <description>Differences in Tricuspid Annular Plane Systolic Excursion measured through two-dimensional transthoracic echocardiography (apical four-chamber view)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right heart function - S'</measure>
    <time_frame>Baseline (PEEP 10 cmH2O), at titrated PEEP level and at titrated PEEP level after a recruitment maneuver</time_frame>
    <description>Differences in the systolic excursion of the tricuspid annulus measured by tissue doppler imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right heart function - Tei index</measure>
    <time_frame>Baseline (PEEP 10 cmH2O), at titrated PEEP level and at titrated PEEP level after a recruitment maneuver</time_frame>
    <description>Differences in global right ventricular function obtained from right ventricle tissue doppler imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamics</measure>
    <time_frame>24 hours after the performance of the study protocol</time_frame>
    <description>Arterial blood pressure, urinary output, water balance, requirement for vasopressors, serum creatinine will be collected</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>30 days after the performance of the study protocol</time_frame>
    <description>Number of days on mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU and hospital length of stay</measure>
    <time_frame>30 days after the performance of the study protocol</time_frame>
    <description>Numbers of days spent in the intensive care unit and numbers of days of in-hospital care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of tracheostomy</measure>
    <time_frame>30 days after the performance of the study protocol</time_frame>
    <description>Necessity of tracheostomy for prolonged ventilatory support among the study population</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>30 days after the performance of the study protocol</time_frame>
    <description>Incidence of death among the study population</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Obesity</condition>
  <condition>Respiratory Insufficiency</condition>
  <condition>Right-Sided Heart Failure</condition>
  <condition>Pulmonary Atelectasis</condition>
  <condition>Respiratory Mechanics</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ICU patients with a BMI &gt; 35 Kg/m2 , mechanically ventilated, non Acute Respiratory Distress Syndrome</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Recruitment maneuver</intervention_name>
    <description>Progressive increase in airway pressure to open lungs atelectatic regions.</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PEEP titration</intervention_name>
    <description>PEEP will be decreased at consecutive steps. Static compliance of the respiratory system will be measured at each step. The optimal PEEP value for the patient will be chosen as the lowest PEEP level at witch the compliance of the respiratory system will be the best.</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ICU admitted requiring intubation and mechanical ventilation

          -  BMI ≥ 35 kg/m2

          -  Waist circumference &gt; 88 cm (for women)

          -  Waist circumference &gt; 102 cm (for men)

        Exclusion Criteria:

          -  Known presence of esophageal varices

          -  Recent esophageal trauma or surgery

          -  Severe thrombocytopenia (Platelets count ≤ 5,000/mm3)

          -  Severe coagulopathy (INR ≥ 4)

          -  Presence or history of pneumothorax

          -  Pregnancy

          -  Patients with poor oxygenation index at screening (PaO2/FiO2&lt; 100 mmHg with at least
             10 cmH2O of PEEP)

          -  Pacemaker and/or internal cardiac defibrillator

          -  Hemodynamic parameters: systolic blood pressure (SBP) &lt;100 mmHg and &gt;180 mmHg, or if
             SBP is between 100-180 mmHg on high dose of IV continuous infusion norepinephrine
             (&gt;20 μg per minute), or dobutamine (&gt;10 μg per minute), or dopamine (&gt;10 μg per Kg
             per minute), or epinephrine (&gt;10 μg per minute).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Kacmarek, RRT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lorenzo Berra, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lorenzo Berra, MD</last_name>
    <phone>6176437733</phone>
    <email>lberra@partners.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Akoumianaki E, Maggiore SM, Valenza F, Bellani G, Jubran A, Loring SH, Pelosi P, Talmor D, Grasso S, Chiumello D, Guérin C, Patroniti N, Ranieri VM, Gattinoni L, Nava S, Terragni PP, Pesenti A, Tobin M, Mancebo J, Brochard L; PLUG Working Group (Acute Respiratory Failure Section of the European Society of Intensive Care Medicine).. The application of esophageal pressure measurement in patients with respiratory failure. Am J Respir Crit Care Med. 2014 Mar 1;189(5):520-31. doi: 10.1164/rccm.201312-2193CI. Review.</citation>
    <PMID>24467647</PMID>
  </reference>
  <reference>
    <citation>Behazin N, Jones SB, Cohen RI, Loring SH. Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity. J Appl Physiol (1985). 2010 Jan;108(1):212-8. doi: 10.1152/japplphysiol.91356.2008. Epub 2009 Nov 12.</citation>
    <PMID>19910329</PMID>
  </reference>
  <reference>
    <citation>Borges JB, Suarez-Sipmann F, Bohm SH, Tusman G, Melo A, Maripuu E, Sandström M, Park M, Costa EL, Hedenstierna G, Amato M. Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse. J Appl Physiol (1985). 2012 Jan;112(1):225-36. doi: 10.1152/japplphysiol.01090.2010. Epub 2011 Sep 29.</citation>
    <PMID>21960654</PMID>
  </reference>
  <reference>
    <citation>Reinius H, Jonsson L, Gustafsson S, Sundbom M, Duvernoy O, Pelosi P, Hedenstierna G, Fredén F. Prevention of atelectasis in morbidly obese patients during general anesthesia and paralysis: a computerized tomography study. Anesthesiology. 2009 Nov;111(5):979-87. doi: 10.1097/ALN.0b013e3181b87edb.</citation>
    <PMID>19809292</PMID>
  </reference>
  <reference>
    <citation>Victorino JA, Borges JB, Okamoto VN, Matos GF, Tucci MR, Caramez MP, Tanaka H, Sipmann FS, Santos DC, Barbas CS, Carvalho CR, Amato MB. Imbalances in regional lung ventilation: a validation study on electrical impedance tomography. Am J Respir Crit Care Med. 2004 Apr 1;169(7):791-800. Epub 2003 Dec 23.</citation>
    <PMID>14693669</PMID>
  </reference>
  <reference>
    <citation>Costa EL, Lima RG, Amato MB. Electrical impedance tomography. Curr Opin Crit Care. 2009 Feb;15(1):18-24. Review.</citation>
    <PMID>19186406</PMID>
  </reference>
  <reference>
    <citation>Krishnan S, Schmidt GA. Acute right ventricular dysfunction: real-time management with echocardiography. Chest. 2015 Mar;147(3):835-46. doi: 10.1378/chest.14-1335. Review.</citation>
    <PMID>25732449</PMID>
  </reference>
  <reference>
    <citation>Vieillard-Baron A, Jardin F. Why protect the right ventricle in patients with acute respiratory distress syndrome? Curr Opin Crit Care. 2003 Feb;9(1):15-21. Review.</citation>
    <PMID>12548024</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 8, 2017</lastchanged_date>
  <firstreceived_date>July 17, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Robert M. Kacmarek</investigator_full_name>
    <investigator_title>RRT, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Pulmonary Atelectasis</mesh_term>
    <mesh_term>Dextrocardia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
